High dose Chemotherapy and Autologous Stem Cell Transplantation for Poor Risk and Recurrent Non-Hodpkin`s Lymphoma: A Single-Center Experience of 50 Patients-Reference-Cited by-同舟云学术

High dose Chemotherapy and Autologous Stem Cell Transplantation for Poor Risk and Recurrent Non-Hodpkin`s Lymphoma: A Single-Center Experience of 50 Patients

Published:2004-06-30 Issue:2 Volume:19 Page:114-120
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Shim Byoung Yong,Lee Myoung A,Byun Jae Ho,Roh Sang Young,Song Chi Won,Park Jin No,Lee Jong Wook,Min Woo Sung,Hong Young Seon,Kim Chun Choo

Publisher

Korean Association of Internal Medicine

Link

http://www.kjim.org/upload/kjim-19-2-114-8.pdf

Reference28 articles.

1. The present status of therapy for patients with aggressive non-Hodgkin’s lymphoma

2. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

3. Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Total Body Irradiation Before and After Chemotherapy in Pretreatment for Hematopoietic Stem Cell Transplantation;Cancer Biotherapy and Radiopharmaceuticals;2012-03

2. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant;Bone Marrow Transplantation;2007-07-16

3. Efficacy of CD34+ Stem Cell Dose in Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation after Total Body Irradiation;Biology of Blood and Marrow Transplantation;2007-03

4. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant;International Journal of Radiation Oncology*Biology*Physics;2006-10